Selected research
Market Structure
Global Sodium Valproate SR Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sodium Valproate SR Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sodium Valproate SR Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sodium Valproate SR Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Valproate SR Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sodium Valproate SR Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Valproate SR Tablet include Taiwan Biotech Co., Ltd., Sanofi and Jiangsu Hengrui Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sodium Valproate SR Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sodium Valproate SR Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sodium Valproate SR Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Valproate SR Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Sodium Valproate SR Tablet Segment by Company
Taiwan Biotech Co., Ltd.
Sanofi
Jiangsu Hengrui Pharmaceutical Co., Ltd.
Sodium Valproate SR Tablet Segment by Type
Original Medication
Generic Medication
Sodium Valproate SR Tablet Segment by Application
Hospital
Drugstore
Other
Sodium Valproate SR Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Valproate SR Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Valproate SR Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Valproate SR Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sodium Valproate SR Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Valproate SR Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sodium Valproate SR Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sodium Valproate SR Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Medication
- Generic Medication
Applications
- Hospital
- Drugstore
- Other
Companies covered
- Taiwan Biotech Co., Ltd.
- Sanofi
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sodium Valproate SR Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sodium Valproate SR Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sodium Valproate SR Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sodium Valproate SR Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sodium Valproate SR Tablet Market Dynamics
- 2.1 Sodium Valproate SR Tablet Industry Trends
- 2.2 Sodium Valproate SR Tablet Industry Drivers
- 2.3 Sodium Valproate SR Tablet Industry Opportunities and Challenges
- 2.4 Sodium Valproate SR Tablet Industry Restraints
3 Sodium Valproate SR Tablet Market by Manufacturers
- 3.1 Global Sodium Valproate SR Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Sodium Valproate SR Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Sodium Valproate SR Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sodium Valproate SR Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Valproate SR Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sodium Valproate SR Tablet Manufacturers, Product Type & Application
- 3.7 Global Sodium Valproate SR Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Valproate SR Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Valproate SR Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Valproate SR Tablet Tier 1, Tier 2, and Tier 3
4 Sodium Valproate SR Tablet Market by Type
- 4.1 Sodium Valproate SR Tablet Type Introduction
- 4.1.1 Original Medication
- 4.1.2 Generic Medication
- 4.2 Global Sodium Valproate SR Tablet Sales by Type
- 4.2.1 Global Sodium Valproate SR Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sodium Valproate SR Tablet Sales by Type (2021-2032)
- 4.2.3 Global Sodium Valproate SR Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Sodium Valproate SR Tablet Revenue by Type
- 4.3.1 Global Sodium Valproate SR Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sodium Valproate SR Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Sodium Valproate SR Tablet Revenue Market Share by Type (2021-2032)
5 Sodium Valproate SR Tablet Market by Application
- 5.1 Sodium Valproate SR Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drugstore
- 5.1.3 Other
- 5.2 Global Sodium Valproate SR Tablet Sales by Application
- 5.2.1 Global Sodium Valproate SR Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sodium Valproate SR Tablet Sales by Application (2021-2032)
- 5.2.3 Global Sodium Valproate SR Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Sodium Valproate SR Tablet Revenue by Application
- 5.3.1 Global Sodium Valproate SR Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sodium Valproate SR Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Sodium Valproate SR Tablet Revenue Market Share by Application (2021-2032)
6 Global Sodium Valproate SR Tablet Sales by Region
- 6.1 Global Sodium Valproate SR Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sodium Valproate SR Tablet Sales by Region (2021-2032)
- 6.2.1 Global Sodium Valproate SR Tablet Sales by Region (2021-2026)
- 6.2.2 Global Sodium Valproate SR Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sodium Valproate SR Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sodium Valproate SR Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sodium Valproate SR Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sodium Valproate SR Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sodium Valproate SR Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sodium Valproate SR Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sodium Valproate SR Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sodium Valproate SR Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sodium Valproate SR Tablet Revenue by Region
- 7.1 Global Sodium Valproate SR Tablet Revenue by Region
- 7.1.1 Global Sodium Valproate SR Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sodium Valproate SR Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Sodium Valproate SR Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Sodium Valproate SR Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sodium Valproate SR Tablet Revenue (2021-2032)
- 7.2.2 North America Sodium Valproate SR Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sodium Valproate SR Tablet Revenue (2021-2032)
- 7.3.2 Europe Sodium Valproate SR Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sodium Valproate SR Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sodium Valproate SR Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sodium Valproate SR Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sodium Valproate SR Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Taiwan Biotech Co., Ltd.
- 8.1.1 Taiwan Biotech Co., Ltd. Company Information
- 8.1.2 Taiwan Biotech Co., Ltd. Business Overview
- 8.1.3 Taiwan Biotech Co., Ltd. Sodium Valproate SR Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Taiwan Biotech Co., Ltd. Sodium Valproate SR Tablet Product Portfolio
- 8.1.5 Taiwan Biotech Co., Ltd. Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Sodium Valproate SR Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Sodium Valproate SR Tablet Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Jiangsu Hengrui Pharmaceutical Co., Ltd.
- 8.3.1 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Jiangsu Hengrui Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. Sodium Valproate SR Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. Sodium Valproate SR Tablet Product Portfolio
- 8.3.5 Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sodium Valproate SR Tablet Value Chain Analysis
- 9.1.1 Sodium Valproate SR Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sodium Valproate SR Tablet Production Mode & Process
- 9.2 Sodium Valproate SR Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sodium Valproate SR Tablet Distributors
- 9.2.3 Sodium Valproate SR Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst